Bristol-Myers Squibb Company

01/20/2021 | Press release | Distributed by Public on 01/20/2021 06:03

U.S. Food and Drug Administration Accepts for Priority Review Application for Opdivo® (nivolumab) Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric[...]